ABEDEL ABUSHMAIES, MD
Vascular Surgery Physician in BATTLE CREEK, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: ABEDEL ABUSHMAIES, MD reported a CMS MIPS final score of 99.2574 out of 100, above the 83.1 national average, and filed 639 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
ABEDEL ABUSHMAIES, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
ABEDEL ABUSHMAIES, MD at a glance
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Michigan
How Vascular Surgery Physician compares to other specialties among Michigan providers
Vascular Surgery Physician share within Michigan
Vascular Surgery Physician is one of the more visible NUCC categories in Michigan
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
ABEDEL ABUSHMAIES, MD's 2023 MIPS final score plotted against the Vascular Surgery Physician national average
- MIPS Final Score
- 99.2574/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Vascular Surgery Physician) — 99.2574/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Vascular Surgery Physician US NPIs
99.2574/100 MIPS final score — 16.2 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Vascular Surgery Physician. Quality dim: 100. Cost dim: 81.828.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ABEDEL ABUSHMAIES, MD is a Vascular Surgery Physician provider practicing in BATTLE CREEK, Michigan, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1003875840. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
ABEDEL ABUSHMAIES, MD appears in the CMS NPPES registry as a Vascular Surgery Physician provider holding MD credentials at 2845 CAPITAL AVE SW, BATTLE CREEK, MI, 49015, with a listed phone of (269) 979-6310. NPI 1003875840 was issued on 03/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ABUSHMAIES most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 639 prescription claims written by this provider, covering 148 Medicare beneficiaries and totaling roughly $178K in drug spend, split 30% brand-name and 70% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.2574/100 for the 2023 performance year (Quality 100, Cost 81.828), compared with the national average of 83.1.
Vascular Surgery Physician is a narrow specialty nationwide, with 4,215 enrolled providers across 53 states and an average of 205 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1003875840 |
|---|---|
| Specialty | Vascular Surgery Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 03/21/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ABEDEL ABUSHMAIES, MD's current license status, disciplinary history, and board certifications with the Michigan Department of Licensing and Regulatory Affairs in Michigan before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ABEDEL ABUSHMAIES, MD. Source: openpaymentsdata.cms.gov.
Total received
$26.5K
Largest payer
AngioDynamics, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Michigan MI-BOM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to ABEDEL ABUSHMAIES, MD. To verify ABEDEL ABUSHMAIES, MD's current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
30% brand-name claims vs 70% generic, on 639 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 920
- Total Day Supply
- 24,258
- Brand vs Generic
- 30% brand / 70% generic
- Brand Drug Cost
- $148K
- Generic Drug Cost
- $30K
- Antibiotic Claims
- 124
Patient Demographics
- Average Patient Age
- 72.4 years
- Avg HCC Risk Score
- 2.07
- Gender Split
- 47% female / 53% male
- Age Distribution
- <65: 19, 65-74: 70, 75-84: 47, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Clopidogrel Clopidogrel Bisulfate | 284 |
| Xarelto Rivaroxaban | 121 |
| Eliquis Apixaban | 66 |
| Linezolid | 25 |
| Levofloxacin | 24 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 22 |
| Clindamycin Hcl | 18 |
| Daptomycin | 15 |
| Doxycycline Hyclate | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Vascular Surgery Physician Overview
How ABEDEL ABUSHMAIES, MD fits within the Vascular Surgery Physician landscape nationally.
ABEDEL ABUSHMAIES, MD's 639 claims are above the specialty average of 205.
Nearby Vascular Surgery Physician Providers in Michigan
Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as ABUSHMAIES.
Compare Vascular Surgery Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Michigan
Frequently Asked Questions
What is ABEDEL ABUSHMAIES, MD's specialty? ▼
How much does ABEDEL ABUSHMAIES, MD prescribe under Medicare Part D? ▼
What is ABEDEL ABUSHMAIES, MD's Medicare quality score? ▼
Where is ABEDEL ABUSHMAIES, MD located? ▼
What is ABEDEL ABUSHMAIES, MD's NPI number? ▼
Does ABEDEL ABUSHMAIES, MD prescribe more brand-name or generic drugs? ▼
How many Vascular Surgery Physician providers are there in the US? ▼
What drugs does ABEDEL ABUSHMAIES, MD prescribe most often? ▼
Does ABEDEL ABUSHMAIES, MD accept Medicare? ▼
How can I verify ABEDEL ABUSHMAIES, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology